VERTEX PHARMACEUTICALS INC / MA ($VRTX)
Filing Information
| Accession Number | 0000875320-26-000098 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
9,060
Total Value
$1,582,117.88
P&L
+inf% (+$2,628,206.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Reg. & Quality Off. | Common Stock | โ | Feb 17, 2026 | Grant/Award | 5,789 | $0.00 | $0.00 | 51,921 | Direct | โ | View Details | |
EVP, Chief Reg. & Quality Off. | Common Stock | โ | Feb 17, 2026 | Tax Withholding | 2,294 | $483.75 | $1,109,722.50 | 49,627 | Direct | โ | View Details | |
EVP, Chief Reg. & Quality Off. | Common Stock | โ | Feb 17, 2026 | Sale | 609 | $489.46 | $298,081.14 | 49,018 | Direct | โ | View Details | |
EVP, Chief Reg. & Quality Off. | Common Stock | โ | Feb 18, 2026 | Sale | 368 | $473.68 | $174,314.24 | 48,650 | Direct | โ | View Details |